Nu Skin Still Undervalued, Even After Earnings Upgrade - trackseekingalpha

Sign Up | Log In | What is SocialPicks?

Nu Skin Still Undervalued, Even After Earnings Upgrade
Oct 04, 2009 09:03 AM UTC

trackseekingalpha

Return	Risk
-11.17%	HIGH

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
NUS	n/a

Via Long Investment Ideas from Seeking Alpha:

One of our favorite "demographic" plays (see our September 23rd Seeking Alpha article), Nu Skin Enterprises Inc. (NUS) climbed more than six percent and hit an new three-year high on an earnings upgrade from Stifel Nicolaus.

Stifel's Mark Astrachan said in a note to clients that he met with the direct-seller of personal care product's Chief Financial Officer Ritch Wood, and came away believing the company is at "the beginning of an acceleration in revenue growth due to the pending launch of ageLOC." Astrachan raised his third-quarter and fourth-quarter earnings estimates by two cents each to 35 cents and 31 cents, respectively. He also upped its 2010 earnings-per-share estimates to $1.45 from $1.41. And he raised his price target by $2 to $22.

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.